# Unlocking the serine mischarging paradox and inhibiting lactyltransferase activity of AlaRS by a single-point mutation

**Authors:** Wooyoung Park, Se-Young Son, Joonyeop Yi, Seungwoo Cha, Hankyeol Moon, Minyoung Kim, Sangho Ji, Wookyung Yu, Changmin Sung, Sun-Shin Cha, Ji-Sook Hahn

PMC · DOI: 10.1093/nar/gkaf462 · Nucleic Acids Research · 2025-06-06

## TL;DR

A single mutation in alanyl-tRNA synthetase prevents serine misactivation and lactyltransferase activity, offering new insights into enzyme function and potential applications.

## Contribution

A single-point mutation (L219M) in AlaRS eliminates serine misactivation and lactyltransferase activity, revealing a novel mechanism independent of editing domains.

## Key findings

- The L219M mutation in AlaRS from Methylomonas sp. DH-1 prevents serine misactivation by altering Val204 flexibility.
- AlaRSL219M mutation also eliminates lactyltransferase activity, potentially explaining enhanced lactate tolerance in evolved strains.
- The findings suggest a new pathway for creating high-fidelity, lactylation-deficient AlaRS mutants for physiological studies.

## Abstract

Aminoacyl-tRNA synthetases are critical for accurate genetic translation, attaching amino acids to their corresponding transfer RNA molecules. Alanyl-tRNA synthetase (AlaRS) often misactivates Ser or Gly instead of Ala, which is detrimental unless corrected by its editing functions. The paradox of misactivating larger Ser by AlaRS was considered inevitable due to its inherent design, sharing an essential acidic residue to accommodate the activated adenylated intermediates from both cognate and non-cognate amino acids. Here we show a groundbreaking discovery where a single-point mutation, L219M, in AlaRS from Methylomonas sp. DH-1, effectively eliminates Ser misactivation. Structural analysis of the pre-activation state unveiled that the flexibility of Val204 is the key to preventing Ser binding in AlaRSL219M. This research elucidates the amino acid discrimination mechanism in AlaRS, independent of editing domain. Remarkably, the AlaRSL219M mutation was initially identified as a causal mutation enhancing lactate tolerance in a strain developed through adaptive laboratory evolution. We showed that AlaRSL219M also eliminates the enzyme’s inherent lactyltransferase activity, suggesting that the lactate tolerance observed might result from preventing excessive protein lactylation under lactate stress. This opens possibilities for developing high-fidelity and lactylation-deficient AlaRS mutants across various organisms, facilitating studies on their potential benefits in different physiological scenarios.

Graphical Abstract

## Linked entities

- **Proteins:** AlaRS (Alanyl-tRNA synthetase)
- **Chemicals:** lactate (PubChem CID 61503)
- **Species:** Methylomonas sp. DH-1 (taxon 1727196)

## Full-text entities

- **Genes:** AARS1 (alanyl-tRNA synthetase 1) [NCBI Gene 16] {aka AARS, CMT2N, DEE29, EIEE29, HDLS2, TTD8}
- **Chemicals:** Ser (MESH:D012694), amino acid (MESH:D000596), lactate (MESH:D019344)
- **Species:** Methylomonas sp. (species) [taxon 418]
- **Mutations:** Gly instead of Ala, L219M

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12143591/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12143591/full.md

## References

50 references — full list in the complete paper: https://tomesphere.com/paper/PMC12143591/full.md

---
Source: https://tomesphere.com/paper/PMC12143591